Indian Pharmaceutical Alliance

Indian Pharmaceutical Alliance IPA is an alliance of 23 leading Indian pharmaceutical companies, committed to patient care in India and across the world.

15/10/2025

India speaks. GST 2.0 delivers
From affordable medicines to accessible healthcare - here's how the are resonating with people.

Narendra Modi | Department of Pharmaceuticals | MyGovIndia | Nirmala Sitharaman | Piyush Goyal | Ministry of Finance, Government of India | Department of Commerce, GoI

That's a wrap on our IPA Masterclass on “Pharma Launch Excellence: Global Insights” with McKinsey & Company. The discus...
14/10/2025

That's a wrap on our IPA Masterclass on “Pharma Launch Excellence: Global Insights” with McKinsey & Company. The discussion focused on three key questions central to successful pharma launches:

1. What is the environment you are looking at to launch in the US?
2. What is the recipe for a successful launch that maximises value creation?
3. For first-time launchers - how do they fare, and how can you tilt the odds of success?

A major highlight was the discussion on how Generative AI is revolutionizing the launch process, helping teams analyze complex data and accelerate commercial ex*****on.

The panel also drove home foundational success factors for first-time launchers, including the need to invest heavily in commercial activities and design portfolios for long-term success in areas of high unmet need.

A huge thank you to our speakers Nicholas Mills, Sathya Prathipati, Pablo Salazar, Anirudh Roy Popli, and moderator Shridhar Narayanan for the invaluable insights.

Counting down the final hours!Today, IPA in collaboration with McKinsey & Company brings you the Masterclass on Pharma L...
14/10/2025

Counting down the final hours!

Today, IPA in collaboration with McKinsey & Company brings you the Masterclass on Pharma Launch Excellence: Global Insights.

This exclusive session will bring together leading voices from across the globe to decode what it takes to deliver launch excellence in today’s pharma landscape.

🗓️ Date: October 14, 2025
🕒 Time: 5:00 – 6:30 PM IST
📍 Register here: https://forms.gle/vZq7cjrU4LY3n4rq8
Learn more: https://tinyurl.c

Building the ‘Laboratory for the World’IPA x CSIR, India | Accelerating Pharma Innovation for Viksit Bharat 2047India’s ...
14/10/2025

Building the ‘Laboratory for the World’
IPA x CSIR, India | Accelerating Pharma Innovation for Viksit Bharat 2047

India’s next leap in healthcare leadership will come from deep science, strong industry–research collaboration, and a shared vision of innovation for all.

In this spirit, the Indian Pharmaceutical Alliance (IPA) and the Council of Scientific and Industrial Research (CSIR) have forged a deeper alliance to accelerate drug discovery, biologics development, and translational research, a key step toward realising Viksit Bharat 2047.

What this partnership enables:
• Harnessing CSIR’s cutting-edge capabilities across its network of institutes spanning research leads in cancer, obesity, Parkinson’s, and CAR-T therapies with strong potential for industry–research collaboration
• A flexible framework for industry participation from problem statement to commercialisation
• Focus on diseases of national priority
• Emphasis on platform technologies: mRNA, CRISPR-CAS, ADCs, and AI/ML-driven drug discovery
• Utilisation of CSIR’s Innovation Complex (Mumbai) to bridge translational gaps

This sustained engagement, backed by the government, will be pivotal in building India’s leadership in innovative, accessible, and affordable pharmaceuticals.

GST 2.0 is a game-changer for India's healthcare future! This reform not only makes medicines more affordable but also c...
13/10/2025

GST 2.0 is a game-changer for India's healthcare future! This reform not only makes medicines more affordable but also creates a strong foundation for innovation and R&D. The article by Samir Mehta, Chairman, Torrent Pharmaceuticals Limited, gives insight into how this move will strengthen public health and enhance access to essential healthcare.

🔗 Read more: https://tinyurl.com/48ma82sx

Narendra Modi | Department of Pharmaceuticals | MyGovIndia | Nirmala Sitharaman | Piyush Goyal | Ministry of Finance, Government of India | Department of Commerce, GoI

Just 1 Day to Go!The countdown is almost over for IPA’s Masterclass on Pharma Launch Excellence: Global Insights, in col...
13/10/2025

Just 1 Day to Go!

The countdown is almost over for IPA’s Masterclass on Pharma Launch Excellence: Global Insights, in collaboration with McKinsey & Company.

Gain first-hand insights from global leaders driving launch excellence worldwide:

Nicholas Mills – Senior Partner, McKinsey & Co., US

Sathya Prathipati – Senior Partner, McKinsey & Co., India

Pablo Salazar – Partner, McKinsey & Co., US

Anirudh Roy Popli – Partner, McKinsey & Co., India

🗓 Date: October 14, 2025

🕒 Time: 5:00 – 6:30 PM IST

📍 Register here: https://forms.gle/vZq7cjrU4LY3n4rq8

Learn more: https://tinyurl.com/4neuuptz

Just 3 Days to Go!Get ready for IPA’s Masterclass on Pharma Launch Excellence: Global Insights, in collaboration with Mc...
11/10/2025

Just 3 Days to Go!

Get ready for IPA’s Masterclass on Pharma Launch Excellence: Global Insights, in collaboration with McKinsey & Company.

A power-packed session bringing you world-class perspectives on achieving launch excellence in pharma. Don’t miss this opportunity to gain actionable insights that set new benchmarks for the industry.

🗓 Date: Oct 14, 2025
🕒 Time: 5:00 – 6:30 PM IST
📍 Register here: https://forms.gle/vZq7cjrU4LY3n4rq8

Learn more: https://tinyurl.com/4neuuptz

Join Anirudh Roy Popli, Partner at McKinsey & Company (India), as he shares actionable insights on optimizing operations...
10/10/2025

Join Anirudh Roy Popli, Partner at McKinsey & Company (India), as he shares actionable insights on optimizing operations, marketing, and sales transformations.

With over 16 years of experience advising global life sciences and healthcare leaders, Anirudh brings practical strategies that drive real impact and sustainable growth.

🗓 Date: Oct 14, 2025
🕒 Time: 5–6:30 PM IST
📍 Register now: https://forms.gle/vZq7cjrU4LY3n4rq8

Learn more about the event: https://lnkd.in/dhaM-Xre

On , the Indian Pharmaceutical Alliance stands for a healthier mind for all: - Advancing Patient Care and Access: Ensur...
10/10/2025

On , the Indian Pharmaceutical Alliance stands for a healthier mind for all:

- Advancing Patient Care and Access: Ensuring mental health medicines are available, and pharmacists are ready to provide care.
- Pioneering Research and Innovation: Investing in breakthroughs to find new, effective treatments.
- Support: Championing the well-being of our own healthcare professionals.

Your mental health is a priority. Let’s keep talking and working to ensure mental health is understood, prioritised and supported.

Discover global best practices in product launch, pricing, and asset valuation with Pablo Salazar, Partner at McKinsey &...
09/10/2025

Discover global best practices in product launch, pricing, and asset valuation with Pablo Salazar, Partner at McKinsey & Company (US), at the upcoming IPA Masterclass.

With over a decade of deep expertise in commercial strategy, Pablo has guided global pharma and biotech companies to unlock value, optimize pricing models, and navigate the complexities of regulated markets.

🗓️ Date: Oct 14, 2025
🕒 Time: 5–6:30 PM IST
📍 Register here: https://lnkd.in/dAAuwh4V
Learn more about the event: https://lnkd.in/dhaM-Xre

McKinsey & Company

How can Indian pharma climb the global value chain through launch excellence and innovation?Join us for the IPA Mastercl...
08/10/2025

How can Indian pharma climb the global value chain through launch excellence and innovation?

Join us for the IPA Masterclass with Sathya Prathipati, Senior Partner at McKinsey India.

With over 19 years of experience advising Asia’s leading life sciences companies on strategy and performance, Sathya will share practical insights on what it takes for Indian pharma to compete — and lead — on the global stage.

🗓️ Date: Oct 14, 2025
🕒 Time: 5–6:30 PM IST
📍 Register here: https://forms.gle/vZq7cjrU4LY3n4rq8
Learn more about the event here: https://tinyurl.com/4neuuptz

Gain perspectives from one of India’s foremost experts shaping the next phase of pharmaceutical growth and innovation.

McKinsey & Company

Join us for the IPA Masterclass with Nicholas Mills, Senior Partner at McKinsey & Company (US), as he shares global pers...
07/10/2025

Join us for the IPA Masterclass with Nicholas Mills, Senior Partner at McKinsey & Company (US), as he shares global perspectives on building next-generation commercial excellence in pharma.

With over 18 years of experience in marketing, sales, and commercial transformation, Nicholas has helped lead organizations worldwide redefine how they engage with healthcare professionals and deliver impact at scale.

🗓️ Date: Oct 14, 2025
🕒 Time: 5–6:30 PM IST
📍 Register here: https://forms.gle/vZq7cjrU4LY3n4rq8
Learn more about the event here: https://tinyurl.com/4neuuptz

Don’t miss this opportunity to learn from one of the world’s top experts driving the future of commercial innovation in life sciences.

Address

Santacruz

Website

Alerts

Be the first to know and let us send you an email when Indian Pharmaceutical Alliance posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Indian Pharmaceutical Alliance:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

About IPA

The Indian Pharmaceutical Alliance (IPA) was established in the year 1999 in Mumbai. IPA represents research-based National Pharmaceutical Companies in India. The IPA works closely with the Government on policy-related matters and seeks to imbibe the experiences of the generic pharmaceutical industry internationally. It is also partnering with the Government in the evolution of a patent regime and up-gradation of the regulatory regime in India.

It consists of 24 member companies. IPA accounts for over 85 percent of the private sector investment in pharmaceutical research and development. We contribute more than 80 percent of the country's exports of drugs and pharmaceuticals and service over 57 percent of the domestic market.